The Netherlands Authority for Consumers and Markets provides insight into the application of competition law to the pricing and marketing strategies of originator companies

In brief In a policy paper, the Netherlands Authority for Consumers and Markets (ACM) examines how it can deal under competition law with pricing and marketing strategies of originators which impede the market entry of cheaper generic medicines. It focuses in particular on the strategies aimed at maintaining and prolonging market exclusivity and those intended to influence the prescription behaviour of physicians. Although competition law can be used in some cases, it is not in all instances considered the right tool to challenge strategies considered harmful to the market entry of generic manufacturers and to the availability of cheaper alternatives to consumers. In detail Since the sector inquiry of the European Commission, the pharmaceutical sector has been high on the agenda of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Koen Platteau, Geneviève Borremans, Machteld Hiemstra, The Netherlands Authority for Consumers and Markets provides insight into the application of competition law to the pricing and marketing strategies of originator companies, 24 February 2015, e-Competitions Bulletin February 2015, Art. N° 77232

Visites 115

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues